Clinical Isolation Syndrome of Spinal Cord and Multiple Sclerosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-01

Study Completion Date

2023-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to investigate the factors that influence the progression of patients with clinically isolated spinal cord syndrome to multiple sclerosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

MS Spinal Mobilisation Study

NCT05090709

Multiple Sclerosis

COMPLETED NA

Functional Changes Following Percutaneous Venoplasty in Multiple Sclerosis Patients

NCT01555684

Multiple Sclerosis Chronic Cerebrospinal Venous Insufficiency

WITHDRAWN NA

Changes of Parameters of Transcranial Magnetic Stimulation in Patients With Spinal Cord Injury

NCT00228085

Spinal Cord Injury

UNKNOWN

Functional Neural Regeneration Collagen Scaffold Transplantation in Acute Spinal Cord Injury Patients

NCT02510365

Acute Spinal Cord Injury

UNKNOWN PHASE1

Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study

NCT02482194

Spinal Cord Injury

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study included patients who were first diagnosed with clinically isolated spinal cord syndrome admitted to the Department of Neurology, Peking University Third Hospital between January 2010 and November 2020. According to the result of the outcome is divided into multiple sclerosis and outcome group, analyzing the characteristics of the age, sex, clinical manifestations, imaging features, evoked potential, blood immune antibody results, rate of cerebrospinal fluid routine biochemical synthesis oligoclonal band IgG, extension, nerve dysfunction score spinal cord clinically isolated syndrome and the influence factors, such as the relationship between the outcome of multiple sclerosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Clinical Isolation Syndrome of Spinal Cord Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

multiple sclerosis group

No interventions assigned to this group

non-prognosis group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Diagnosis time and place: Department of Neurology, Peking University Third Hospital from January 2010 to November 2020 Diagnosed as a patient with clinically isolated spinal cord syndrome for the first time